Alexandra Smolyanova,
Dabigatran: how the drug company withheld important analyses http://www.bmj.com/content/349/bmj.g4670
Dabigatran: how the drug company withheld important analyses http://www.bmj.com/content/349/bmj.g4670
Dabigatran: how the drug company withheld important analyses http://www.bmj.com/content/349/bmj.g4670
We should expect more from companies: Dabigatran: how the drug company withheld important analyses http... We should expect…